Empagliflozin users had 741 events compared to 712 in the DPP4i group, corresponding to a non-significant HR of 1.04. For DR progression, empagliflozin users experienced fewer events (158) than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback